Abstract
In this paper, we address the most recent advances in optical technology integrated into microfluidic systems so that the functions or efficiency of these devices can be improved. In addition, we presented valuable applications for these devices. This paper includes following sections: the latest advances in continuous and digital light-actuated microfluidic systems, optical sensors integrated into microfluidic chips, and the latest advances in Taiwan. This is a comprehensive summary for researchers focusing on optical-related microfluidic research.
Keywords: Active elements, passive elements, microfluidic, optical, Optical technology, review.
Graphical Abstract
Current Proteomics
Title:The Application of Optical Technology in Microfluidic Systems
Volume: 11 Issue: 2
Author(s): Chih-Yu Wang, Shu-Chen Chang, Keng-Shiang Huang and Chih-Hui Yang
Affiliation:
Keywords: Active elements, passive elements, microfluidic, optical, Optical technology, review.
Abstract: In this paper, we address the most recent advances in optical technology integrated into microfluidic systems so that the functions or efficiency of these devices can be improved. In addition, we presented valuable applications for these devices. This paper includes following sections: the latest advances in continuous and digital light-actuated microfluidic systems, optical sensors integrated into microfluidic chips, and the latest advances in Taiwan. This is a comprehensive summary for researchers focusing on optical-related microfluidic research.
Export Options
About this article
Cite this article as:
Wang Chih-Yu, Chang Shu-Chen, Huang Keng-Shiang and Yang Chih-Hui, The Application of Optical Technology in Microfluidic Systems, Current Proteomics 2014; 11 (2) . https://dx.doi.org/10.2174/157016461102140917121517
DOI https://dx.doi.org/10.2174/157016461102140917121517 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice
Current Drug Metabolism Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Current Pharmaceutical Design Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Tumor Stroma as a Target in Cancer
Current Cancer Drug Targets An Overview on Pyranocoumarins: Synthesis and Biological Activities
Current Organic Chemistry Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Cancer Therapy Reviews Translation of a Tissue-Selective Rexinoid, UAB30, to the Clinic for Breast Cancer Prevention
Current Topics in Medicinal Chemistry The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Activation of B Cells by a Dendritic Cell-Targeted Oral Vaccine
Current Pharmaceutical Biotechnology Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment
Current Cancer Drug Targets Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
Current Cancer Drug Targets Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Killer Beacons for Combined Cancer Imaging and Therapy
Current Medicinal Chemistry HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Involvement of Nucleotide Excision and Mismatch Repair Mechanisms in Double Strand Break Repair
Current Genomics